BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

February 2006

Living Cell Technologies reports positive meetings with FDA and MedSafe - preparing for cell therapy trials

BioInvent Financial Statement 1 January - 31 December 2005

Lectus Therapeutics closes Series A funding round raising £8.2 million

SIGMA-ALDRICH STRENGTHENS POSITION IN RNAi AND CELL-BASED ASSAYS THROUGH LICENSING AND EQUITY POSITION IN GENOSPECTRA

Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Sales Growth & Diluted EPS of $.84 in Q4 2005

Oxford Immunotec launches new website

Automated Colony Counting of Spiral Plates Improves Patient Care at Major European Teaching Hospital

New CCD Imager for 2D Protein Gels Is an Accurate, Cost-effective Alternative to Laser Scanners

NIH TAKES TO ACUMEN EXPLORER TTP LabTech allows NIH to match high content with high throughput

SOLEXA ANNOUNCES TECHNICAL MILESTONES AT THE AGBT CONFERENCE

ABLYNX ANNOUNCES RESEARCH COLLABORATION WITH KIRIN BREWERY

Bio-based economy moves one step closer as Commission publishes new biofuels strategy

Can therapeutic vaccines fulfill their promise?

EuropaBio statement on WTO ruling on biotech crops

MNLpharma announces exclusive licence agreement with Avexa to develop new compounds to treat HIV/AIDS

Oxford Immunotec's T-SPOT.TB is first test to demonstrate accurate diagnosis of latent TB in HIV patients - Results published in journal AIDS

Dosing convenience mandates the pipeline of glucagon-like peptide-1 (GLP-1) analogs for type 2 diabetes

New Technology for Accelerating Development of Vaccines Against H5N1 Flu Enters Pilot Study at ProImmune

Developing Microarray-based Genetic Tests for Use in NHS Laboratories

DNAVISION ANNOUNCES DISTRIBUTION AGREEMENT WITH EUROGENTEC FOR PREMATURE MicroRNA QUANTITATION TOOLS

OXFORD BIOMEDICA ANNOUNCES BOARD APPOINTMENT

SIGMA-ALDRICH LAUNCHES FIRST LENTIVIRAL shRNA GENE FAMILY SET

SOLEXA GRANTED EUROPEAN PATENT ON USE OF SINGLE MOLECULES FOR SEQUENCING

AstraZeneca's Symbicort gives asthma patients the power to get SMART

COPD: The Silent Killer

Geneservice Announce the Appointment of Dr Andy Richards as Non-Executive Chairman

9th PHARLEX® pharma license exchange partners with the 3rd Annual Florida Tech Transfer Conference

GemacBio announces the successful conclusion of Phase IIa clinical trials for its new molecule designed to treat multiple sclerosis

ibidi extends partnership with Applied Biophysics

SCIpharm - Exhibitors show support for SCIpharm 200

Oxford Immunotec announces launch of second generation product based on co-development with Millipore

Trophos successfully completes phase 1 clinical trials for novel compound to treat neurodegenerative diseases

Emerging diabetes drugs in early development

York Pharma: Update on Psoriasis treatment (YP003) ANALYST MEETING TODAY

Cobra Signs Contract with Replikun Biotech for Novel Gene Therapy Approach

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

Site Map - new news site

Site Map - old news site
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.